Literature DB >> 29450404

Reengineering deep brain stimulation for movement disorders: Emerging technologies.

Aysegul Gunduz1,2, Kelly D Foote2,3, Michael S Okun2,4.   

Abstract

Deep brain stimulation (DBS) is a neurosurgical technique, which consists of continuous delivery of an electrical pulse through chronically implanted electrodes connected to a neurostimulator, programmable in amplitude, pulse width, frequency, and stimulation channel. DBS is a promising treatment option for addressing severe and drug-resistant movement disorders. The success of DBS therapy is a combination of surgical implantation techniques, device technology, and clinical programming strategies. Changes in device settings require highly trained and experienced clinicians to achieve maximal therapeutic benefit for each targeted symptom, and optimization of stimulation parameters can take many visits. Thus, the development of innovative DBS technologies that can optimize the clinical implementation of DBS will lead to wider scale utilization. This review aims to present engineering approaches that have the potential to improve clinical outcomes of DBS, focusing on the development novel temporal patterns, innovative electrode designs, computational models to guide stimulation, closed-loop DBS, and remote programming.

Entities:  

Keywords:  DBS; Deep brain stimulation; Movement disorders; Neuromodulation; Neurostimulator

Year:  2017        PMID: 29450404      PMCID: PMC5808611          DOI: 10.1016/j.cobme.2017.09.001

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  39 in total

Review 1.  Mechanisms of deep brain stimulation and future technical developments.

Authors:  E B Montgomery; K B Baker
Journal:  Neurol Res       Date:  2000-04       Impact factor: 2.448

2.  A template subtraction method for stimulus artifact removal in high-frequency deep brain stimulation.

Authors:  Takao Hashimoto; Christopher M Elder; Jerrold L Vitek
Journal:  J Neurosci Methods       Date:  2002-01-30       Impact factor: 2.390

Review 3.  How does deep brain stimulation work? Present understanding and future questions.

Authors:  Cameron C McIntyre; Marc Savasta; Benjamin L Walter; Jerrold L Vitek
Journal:  J Clin Neurophysiol       Date:  2004 Jan-Feb       Impact factor: 2.177

4.  Patient-specific analysis of the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Scott E Cooper; Jaimie M Henderson; Cameron C McIntyre
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

5.  Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.

Authors:  Michael S Okun; Michele Tagliati; Michael Pourfar; Hubert H Fernandez; Ramon L Rodriguez; Ron L Alterman; Kelly D Foote
Journal:  Arch Neurol       Date:  2005-06-13

6.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

7.  Patient-specific models of deep brain stimulation: influence of field model complexity on neural activation predictions.

Authors:  Ashutosh Chaturvedi; Christopher R Butson; Scott F Lempka; Scott E Cooper; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2010-04       Impact factor: 8.955

8.  What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease?

Authors:  Simon Little; Peter Brown
Journal:  Ann N Y Acad Sci       Date:  2012-07-25       Impact factor: 5.691

Review 9.  Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Authors:  P Justin Rossi; Aysegul Gunduz; Jack Judy; Linda Wilson; Andre Machado; James J Giordano; W Jeff Elias; Marvin A Rossi; Christopher L Butson; Michael D Fox; Cameron C McIntyre; Nader Pouratian; Nicole C Swann; Coralie de Hemptinne; Robert E Gross; Howard J Chizeck; Michele Tagliati; Andres M Lozano; Wayne Goodman; Jean-Philippe Langevin; Ron L Alterman; Umer Akbar; Greg A Gerhardt; Warren M Grill; Mark Hallett; Todd Herrington; Jeffrey Herron; Craig van Horne; Brian H Kopell; Anthony E Lang; Codrin Lungu; Daniel Martinez-Ramirez; Alon Y Mogilner; Rene Molina; Enrico Opri; Kevin J Otto; Karim G Oweiss; Yagna Pathak; Aparna Shukla; Jonathan Shute; Sameer A Sheth; Ludy C Shih; G Karl Steinke; Alexander I Tröster; Nora Vanegas; Kareem A Zaghloul; Leopoldo Cendejas-Zaragoza; Leonard Verhagen; Kelly D Foote; Michael S Okun
Journal:  Front Neurosci       Date:  2016-04-06       Impact factor: 4.677

10.  Randomized, Blinded Pilot Testing of Nonconventional Stimulation Patterns and Shapes in Parkinson's Disease and Essential Tremor: Evidence for Further Evaluating Narrow and Biphasic Pulses.

Authors:  Umer Akbar; Robert S Raike; Nawaz Hack; Christopher W Hess; Jared Skinner; Daniel Martinez-Ramirez; Sol DeJesus; Michael S Okun
Journal:  Neuromodulation       Date:  2016-03-22
View more
  4 in total

1.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

2.  Remote Programming in Patients With Parkinson's Disease After Deep Brain Stimulation: Safe, Effective, and Economical.

Authors:  Pan Nie; Jibo Zhang; Xin Yang; Yuyang Shao; Xiuming Zhang; Wen Liu; Kai Fu; Jincao Chen; Jie Zhang
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

3.  Adjust Neuronal Reactions to Pulses of High-Frequency Stimulation with Designed Inter-Pulse-Intervals in Rat Hippocampus In Vivo.

Authors:  Lvpiao Zheng; Zhouyan Feng; Yifan Hu; Zhaoxiang Wang; Yue Yuan; Gangsheng Yang; Chuchu Lu
Journal:  Brain Sci       Date:  2021-04-16

4.  Subthalamic nucleus deep brain stimulation driven by primary motor cortex γ2 activity in parkinsonian monkeys.

Authors:  Olivier Darbin; Nobuhiko Hatanaka; Sayuki Takara; Nobuya Kaneko; Satomi Chiken; Dean Naritoku; Anthony Martino; Atsushi Nambu
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.